当前位置: X-MOL 学术J. Rheumatol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Simplified Ankylosing Spondylitis Disease Activity Score (SASDAS) Versus ASDAS: A Post Hoc Analysis of a Randomized Controlled Trial.
The Journal of Rheumatology ( IF 3.9 ) Pub Date : 2022-07-15 , DOI: 10.3899/jrheum.211075
Emilce E Schneeberger 1 , Gustavo Citera 2 , Dario Ponce de Leon 3 , Annette E Szumski 4 , Kenneth Kwok 5 , Mariel Cutri 6 , Maxime Dougados 7
Affiliation  

To compare the Simplified Ankylosing Spondylitis Disease Activity Score (SASDAS) against the Ankylosing Spondylitis Disease Activity Score (ASDAS) for measuring and categorizing disease activity using data from the EMBARK trial (ClinicalTrials.gov: NCT01258738), a randomized controlled trial of etanercept (ETN) for axial spondyloarthritis (axSpA).

中文翻译:

简化强直性脊柱炎疾病活动评分 (SASDAS) 与 ASDAS:一项随机对照试验的事后分析。

比较简化强直性脊柱炎疾病活动评分 (SASDAS) 与强直性脊柱炎疾病活动评分 (ASDAS),使用来自 EMBARK 试验(ClinicalTrials.gov:NCT01258738)的数据测量和分类疾病活动,依那西普 (ETN) 的随机对照试验) 用于中轴型脊柱关节炎 (axSpA)。
更新日期:2022-07-15
down
wechat
bug